how do glp-1 agonists work Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review Evolution of GLP‐1 Receptor Agonists

Learn about the benefits and savings opportunities of the SmithRx Weight Management Pathway.

New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs

CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.

The search for over-the-counter GLP-1 alternatives reflects growing interest in weight loss support

Clinical uses Type 2 Diabetes Mellitus (T2DM): Effective in lowering blood glucose without a significant risk of hypoglycemia

Purpose of Review This review explores the role of GLP-1 receptor agonists (GLP-1 RAs) in addressing metabolic dysfunction and neurodegeneration in Parkinsons disease (PD), focusing on body weight regulation and neuroprotection